Lantheus to Sell Nuclear-Imaging Test Unit

Dow Jones

07 May

By Connor Hart

Lantheus Holdings will sell its single photon emission computed tomography, or Spect, business to Illuminated Holdings.

The Bedford, Mass., company said Tuesday it will receive an upfront cash payment for the business, though it didn't disclose the amount. It will additionally receive a convertible note for preferred stock of Shine Technologies, a subsidiary of Illuminated, and additional considerations including potential earnout milestones.

The transaction has been approved by both companies' boards and is expected to close by the end of the year, subject to customary conditions.

Under the deal's terms, Shine will acquire Lantheus' Spect business and related products, as well as the portion of Lantheus' campus in Massachusetts that manufactures the products and the business's related operations in Canada.

Spect is a type of nuclear-imaging test that uses radioactive substances to create three-dimensional images of organs and tissues, showing both their function and structure.

Lantheus said the sale will allow it to focus on growing its commercial portfolio of PET radiodiagnostics and microbubbles, while advancing its pipeline of radiopharmaceuticals.

"This acquisition builds on our longstanding partnership with Lantheus," Shine Chief Executive Greg Piefer said, adding he is confident the Spect business and team will strengthen its platform.

Write to Connor Hart at connor.hart@wsj.com

(END) Dow Jones Newswires

May 06, 2025 17:45 ET (21:45 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2533695526"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2533695526\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2533695526?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-05-07 05:45","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2533695526","market":"sg","top_or_hot":-1,"title":"Lantheus to Sell Nuclear-Imaging Test Unit","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  By Connor Hart \n</p>\n<p>\n  Lantheus Holdings will sell its single photon emission computed tomography, or Spect, business to Illuminated Holdings. \n</p>\n<p>\n  The Bedford, Mass., company said Tuesday it will receive an upfront cash payment for the business, though it didn't disclose the amount. It will additionally receive a convertible note for preferred stock of Shine Technologies, a subsidiary of Illuminated, and additional considerations including potential earnout milestones. \n</p>\n<p>\n  The transaction has been approved by both companies' boards and is expected to close by the end of the year, subject to customary conditions. \n</p>\n<p>\n  Under the deal's terms, Shine will acquire Lantheus' Spect business and related products, as well as the portion of Lantheus' campus in Massachusetts that manufactures the products and the business's related operations in Canada. \n</p>\n<p>\n  Spect is a type of nuclear-imaging test that uses radioactive substances to create three-dimensional images of organs and tissues, showing both their function and structure. \n</p>\n<p>\n  Lantheus said the sale will allow it to focus on growing its commercial portfolio of PET radiodiagnostics and microbubbles, while advancing its pipeline of radiopharmaceuticals. \n</p>\n<p>\n  \"This acquisition builds on our longstanding partnership with Lantheus,\" Shine Chief Executive Greg Piefer said, adding he is confident the Spect business and team will strengthen its platform. \n</p>\n<p>\n  Write to Connor Hart at connor.hart@wsj.com \n</p>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  May 06, 2025 17:45 ET (21:45 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Lantheus to Sell Nuclear-Imaging Test Unit</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLantheus to Sell Nuclear-Imaging Test Unit\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-05-07 05:45</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  By Connor Hart \n</p>\n<p>\n  Lantheus Holdings will sell its single photon emission computed tomography, or Spect, business to Illuminated Holdings. \n</p>\n<p>\n  The Bedford, Mass., company said Tuesday it will receive an upfront cash payment for the business, though it didn't disclose the amount. It will additionally receive a convertible note for preferred stock of Shine Technologies, a subsidiary of Illuminated, and additional considerations including potential earnout milestones. \n</p>\n<p>\n  The transaction has been approved by both companies' boards and is expected to close by the end of the year, subject to customary conditions. \n</p>\n<p>\n  Under the deal's terms, Shine will acquire Lantheus' Spect business and related products, as well as the portion of Lantheus' campus in Massachusetts that manufactures the products and the business's related operations in Canada. \n</p>\n<p>\n  Spect is a type of nuclear-imaging test that uses radioactive substances to create three-dimensional images of organs and tissues, showing both their function and structure. \n</p>\n<p>\n  Lantheus said the sale will allow it to focus on growing its commercial portfolio of PET radiodiagnostics and microbubbles, while advancing its pipeline of radiopharmaceuticals. \n</p>\n<p>\n  \"This acquisition builds on our longstanding partnership with Lantheus,\" Shine Chief Executive Greg Piefer said, adding he is confident the Spect business and team will strengthen its platform. \n</p>\n<p>\n  Write to Connor Hart at connor.hart@wsj.com \n</p>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  May 06, 2025 17:45 ET (21:45 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4585","symbol_name":"ETF&股票定投概念","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2533695526","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2533695526","pubTimestamp":1746567900,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Lantheus Holdings will sell its single photon emission computed tomography, or Spect, business to Illuminated Holdings.The Bedford, Mass., company said Tuesday it will receive an upfront cash payment for the business, though it didn't disclose the amount. It will additionally receive a convertible note for preferred stock of Shine Technologies, a subsidiary of Illuminated, and additional considerations including potential earnout milestones.The transaction has been approved by both companies' boards and is expected to close by the end of the year, subject to customary conditions.Under the deal's terms, Shine will acquire Lantheus' Spect business and related products, as well as the portion of Lantheus' campus in Massachusetts that manufactures the products and the business's related operations in Canada.Spect is a type of nuclear-imaging test that uses radioactive substances to create three-dimensional images of organs and tissues, showing both their function and structure.\"This acquis","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4585":"ETF&股票定投概念","BK4588":"碎股","BK4198":"医疗保健用品","LNTH":"Lantheus Holdings, Inc."},"translate_title":"Lantheus将出售核成像测试装置","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LNTH":1},"content_text":"By Connor Hart \n\n\n  Lantheus Holdings will sell its single photon emission computed tomography, or Spect, business to Illuminated Holdings. \n\n\n  The Bedford, Mass., company said Tuesday it will receive an upfront cash payment for the business, though it didn't disclose the amount. It will additionally receive a convertible note for preferred stock of Shine Technologies, a subsidiary of Illuminated, and additional considerations including potential earnout milestones. \n\n\n  The transaction has been approved by both companies' boards and is expected to close by the end of the year, subject to customary conditions. \n\n\n  Under the deal's terms, Shine will acquire Lantheus' Spect business and related products, as well as the portion of Lantheus' campus in Massachusetts that manufactures the products and the business's related operations in Canada. \n\n\n  Spect is a type of nuclear-imaging test that uses radioactive substances to create three-dimensional images of organs and tissues, showing both their function and structure. \n\n\n  Lantheus said the sale will allow it to focus on growing its commercial portfolio of PET radiodiagnostics and microbubbles, while advancing its pipeline of radiopharmaceuticals. \n\n\n  \"This acquisition builds on our longstanding partnership with Lantheus,\" Shine Chief Executive Greg Piefer said, adding he is confident the Spect business and team will strengthen its platform. \n\n\n  Write to Connor Hart at connor.hart@wsj.com \n\n\n  (END) Dow Jones Newswires\n\n\n  May 06, 2025 17:45 ET (21:45 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"code":"91000000","status":"200"}}}